Search

Your search keyword '"Remke, M."' showing total 398 results

Search Constraints

Start Over You searched for: Author "Remke, M." Remove constraint Author: "Remke, M."
398 results on '"Remke, M."'

Search Results

101. CELL BIOLOGY AND SIGNALING

102. PEDIATRICS CLINICAL RESEARCH

104. Molecular subtypes in medulloblastoma: an International meta-analysis for profiles, genetic aberrations, clinicopathological features AND SURVIVAL

105. FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

107. Identification of Two Molecular and Clinical Distinct Entities of Posterior Fossa Ependymoma

111. Tandem duplications of 7q34 and 3q25 in pilocytic astrocytoma result in RAF fusion genes

124. WIP1modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma

125. Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma.

129. STRATEGIC ENVIRONMENTAL ASSESSMENT FOR SUSTAINABLE HOUSEHOLDS IN 2050: ILLUSTRATED FOR CLOTHING.

131. Intertumoral Heterogeneity within Medulloblastoma Subgroups

132. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis

133. Maker Education Meets Technology Education

134. Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition

135. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

136. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

137. Cytogenetic Prognostication Within Medulloblastoma Subgroups

138. Epigenetic Silencing of DKK3 in Medulloblastoma

139. Subgroup-specific structural variation across 1,000 medulloblastoma genomes

140. HERV-W envelope protein is present in microglial cells of the human glioma tumor microenvironment and differentially modulates neoplastic cell behavior.

141. Histomorphological scoring of murine colitis models: A practical guide for the evaluation of colitis and colitis-associated cancer.

142. A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases.

143. B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation.

144. Mitochondrial perturbation in the intestine causes microbiota-dependent injury and gene signatures discriminative of inflammatory disease.

145. MGA deletion leads to Richter's transformation by modulating mitochondrial OXPHOS.

146. Medulloblastoma subgrouping at first sight.

147. Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia.

149. Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.

150. mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism.

Catalog

Books, media, physical & digital resources